Multiply Labs Raises $75M to Scale Robotic Drug Manufacturing
Multiply Labs raises $75 million to expand robotic biomanufacturing, with AstraZeneca and Teradyne joining the round.
Explore RobotsBeat's latest reporting, research, and expert analysis tagged with "multiply labs", collected in one continuously updated archive.
Multiply Labs raises $75 million to expand robotic biomanufacturing, with AstraZeneca and Teradyne joining the round.
Multiply Labs has partnered with AstraZeneca to automate key steps in cell therapy manufacturing. The collaboration targets scalable, reproducible production of personalized therapies.